Pacritinib and Dolasetron: Interaction Details
- Dolasetron
- Anzemet
- Pacritinib
- Vonjo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Pacritinib and Dolasetron interaction:
What Happens When You Take Pacritinib With Dolasetron
What can happen when they are taken together (rated Major)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Pacritinib should not be given together with any drug known to prolong the . Using other QT-prolonging drugs at the same time may add to the QTc-prolonging effect of pacritinib and raise the risk of cardiac .
Pacritinib should also be avoided in patients whose baseline QTc exceeds 480 msec. Pacritinib should be held if the lengthens beyond 500 msec or rises more than 60 msec above baseline.
When QTc returns to 480 msec or less, or to baseline, within 1 week, pacritinib can be resumed at the same dose. If resolution takes longer than 1 week, pacritinib should be resumed at a reduced dose. When cannot be avoided, should be corrected before and throughout pacritinib treatment, and QTc prolongation should be managed through interruption of pacritinib and management of electrolytes.1
The Pacritinib and Dolasetron Interaction, Explained
Both of these medicines can affect your heart's electrical rhythm. Dolasetron is used to prevent nausea and vomiting, and pacritinib is used for certain bone marrow conditions. Each one can lengthen a heart rhythm measurement called the . Taken together, the effect could add up and raise the chance of an irregular heartbeat. This concern is based on how the drugs work, not on reported cases. Still, it is considered a serious one. Keep taking your medicines as prescribed and ask your pharmacist or doctor about it. Your care team can check your heart tracing and your potassium level, and can adjust your plan if needed. Tell them right away if you feel faint, dizzy, or have a racing or fluttering heartbeat.
Mechanism: () between dolasetron and pacritinib. Direction: increased risk of QTc prolongation and , including .
- Evidence: theoretical; onset unspecified. Severity on file: major.
- Avoid with QT-prolonging drugs. Avoid pacritinib if baseline is above 480 msec.
- Hold pacritinib if QTc exceeds 500 msec or rises more than 60 msec from baseline. Restart at the same dose if QTc returns to 480 msec or less (or baseline) within 1 week. If resolution takes longer, restart at a reduced dose.
- If the combination is unavoidable, correct before and during therapy, monitor and electrolytes, and manage QTc prolongation with pacritinib interruption and electrolyte management.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Pacritinib and Dolasetron Interact
The likely mechanism
How to Manage the Pacritinib and Dolasetron Interaction
Doctors usually try to avoid combining these two. If your team decides you need both, they can manage the risk carefully.
- Your team may check your heart rhythm () and your potassium levels before and during treatment, and correct low potassium if it occurs.
- If your becomes too long, they may pause pacritinib. They may restart it at the same dose if things return to normal within about a week, or at a lower dose if recovery takes longer.
- Pacritinib is generally not used if your QT interval is already long at baseline.
What you should do: keep taking both medicines as prescribed, and ask your pharmacist or prescriber before changing anything. Report fainting, dizziness, or palpitations right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Pacritinib or Dolasetron need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Pacritinib and Dolasetron: Common Questions
How serious is the Pacritinib and Dolasetron interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Pacritinib and Dolasetron interaction managed?
Doctors usually try to avoid combining these two. If your team decides you need both, they can manage the risk carefully. Your team may check your heart rhythm () and your potassium levels before and during treatment, and correct low potassium if it occurs. If your becomes too long, they may pause pacritinib. They may restart it at the same dose if things return to normal within abo… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Pacritinib and Dolasetron Interaction
Ask in your own words about taking Pacritinib and Dolasetron together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Other Serious Interactions of Pacritinib and Dolasetron
Also serious with Dolasetron
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PhenelzineContraindicated
- PimozideContraindicated
Also serious with Pacritinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dolasetron
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- LithiumMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- + 165 more
With Pacritinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 155 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.